S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% BITCOIN 64,670.98 -0.19%
Next Bullish Trade
Sign in
AVTR

Avantor, Inc. AVTR

$11.07 -0.19 (-1.69%)
Extended · +1.65σ
Mkt cap $7.7B
P/E
Day $10.89 – $11.31
52wk $7.26 – $12.51
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

Avantor, Inc. is a healthcare company listed in the US.

AVTR last traded at $11.07, down 1.7% on the day; that's in the upper part of its 52-week range ($7.26–$12.51). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 65), the trend is strong (ADX 39), and volume is about normal (1.2×). On the business side, revenue is growing 0% year over year and the business keeps about 7 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
65
0–100 · <30 oversold
Trend strength · ADX
39
>25 = strong trend
Volume vs avg
1.20×
1× = average
Stretch from avg
+1.6 ATR
− below · + above
Zone touches
4
tests of this zone
Suggested hold
3–30
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth
+0.0%
year over year
Free-cash-flow margin
7.5%
cash kept per $ of sales
Debt / equity
0.68
lower = less leveraged

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $4.19 (fair range $4–$29); today's price sits 168% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)
$4.19
Fair-value range
$4.19 – $28.79
Margin of safety
-168%
Verdict
Overvalued
Accounting quality Weak
  • ✓ Positive retained earnings
  • ⚠ Debt exceeds cash
  • ⚠ Quick ratio 0.98 (fragile)
  • ⚠ Receivables growing faster than revenue
  • ⚠ Inventory growing faster than revenue

Price implies ~10% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

AVTR is a $7.7 billion company.

Mkt cap $7.7B
P/E ttm
Fwd P/E
Beta
Day range $10.89 – $11.31
52w range $7.26 – $12.51
Avg vol
RSI(2) 39.5
ROE
Net mgn
FCF mgn 7.5%
Debt/Eq 0.68
Div yld
Sector Healthcare
Industry Medical Instruments & Supplies
Next earn
52-week range · today's price
$7.26$12.51

More on AVTR